These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31634544)

  • 1. Effects of acrolein in comparison to its prodrug cyclophosphamide on human primary endothelial cells in vitro.
    Lau S; Rangarajan R; Philidet C; Krüger-Genge A; Braune S; Kammerer S; Küpper JH; Lendlein A; Jung F
    Toxicol In Vitro; 2020 Feb; 62():104685. PubMed ID: 31634544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel insights into the mechanism of cyclophosphamide-induced bladder toxicity: chloroacetaldehyde's contribution to urothelial dysfunction in vitro.
    Mills KA; Chess-Williams R; McDermott C
    Arch Toxicol; 2019 Nov; 93(11):3291-3303. PubMed ID: 31598736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide and acrolein induced oxidative stress leading to deterioration of metaphase II mouse oocyte quality.
    Jeelani R; Khan SN; Shaeib F; Kohan-Ghadr HR; Aldhaheri SR; Najafi T; Thakur M; Morris R; Abu-Soud HM
    Free Radic Biol Med; 2017 Sep; 110():11-18. PubMed ID: 28499912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Cancer Prodrug Cyclophosphamide Exerts Thrombogenic Effects on Human Venous Endothelial Cells Independent of CYP450 Activation-Relevance to Thrombosis.
    Krüger-Genge A; Köhler S; Laube M; Haileka V; Lemm S; Majchrzak K; Kammerer S; Schulz C; Storsberg J; Pietzsch J; Küpper JH; Jung F
    Cells; 2023 Jul; 12(15):. PubMed ID: 37566045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Effects of Nonadherent on Adherent Human Umbilical Venous Endothelial Cells in Cell Culture.
    Schulz C; Krüger-Genge A; Lendlein A; Küpper JH; Jung F
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acrolein: unwanted side product or contribution to antiangiogenic properties of metronomic cyclophosphamide therapy?
    Günther M; Wagner E; Ogris M
    J Cell Mol Med; 2008 Dec; 12(6B):2704-16. PubMed ID: 18266977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastases.
    del Olmo M; Alonso-Varona A; Castro B; Calle Y; Bilbao P; Palomares T
    Melanoma Res; 2000 Apr; 10(2):103-12. PubMed ID: 10803710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione S-transferase P protects against cyclophosphamide-induced cardiotoxicity in mice.
    Conklin DJ; Haberzettl P; Jagatheesan G; Baba S; Merchant ML; Prough RA; Williams JD; Prabhu SD; Bhatnagar A
    Toxicol Appl Pharmacol; 2015 Jun; 285(2):136-48. PubMed ID: 25868843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of metabolites of cyclophosphamide in cardiotoxicity.
    Kurauchi K; Nishikawa T; Miyahara E; Okamoto Y; Kawano Y
    BMC Res Notes; 2017 Aug; 10(1):406. PubMed ID: 28807058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of cardiac toxicity caused by cyclophosphamide in the H9c2 cell line and isolated and perfused rat hearts].
    Nakamura S; Aoki M; Mori A; Nakahara T; Sakamoto K; Ishii K
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):677-80. PubMed ID: 20414025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Deposition of von Willebrand factor in human endothelial cells HUVEC in the endoplasmic reticulum stress induced by an excess of homocysteine in vitro].
    Ignashkova TI; Mesitov MV; Rybakov AS; Moskovtsev AA; Sokolovskaia AA; Kubatiev AA
    Patol Fiziol Eksp Ter; 2012; (3):81-6. PubMed ID: 23072117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusible cytotoxic metabolites contribute to the in vitro bystander effect associated with the cyclophosphamide/cytochrome P450 2B1 cancer gene therapy paradigm.
    Wei MX; Tamiya T; Rhee RJ; Breakefield XO; Chiocca EA
    Clin Cancer Res; 1995 Oct; 1(10):1171-7. PubMed ID: 9815909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protective effects and its mechanism of lipoxins on human umbilical vein endothelial cells under hypoxia].
    Liu SJ; Li YS; Zhou XY; Cai L; Liu XL; Huang YJ; Ye DY; Huang YP
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):281-4. PubMed ID: 19570467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine kinases regulate agonist-stimulated prostacyclin release but not von Willebrand factor secretion from human umbilical vein endothelial cells.
    Wheeler-Jones CP; May MJ; Morgan AJ; Pearson JD
    Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):407-16. PubMed ID: 8615807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of acrolein-lysine adducts in plasma low-density lipoprotein and in aorta of cyclophosphamide-administered rats.
    Arikketh D; Niranjali S; Devaraj H
    Arch Toxicol; 2004 Jul; 78(7):397-401. PubMed ID: 15014928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide.
    Plowchalk DR; Mattison DR
    Toxicol Appl Pharmacol; 1991 Mar; 107(3):472-81. PubMed ID: 2000634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained P450 expression and prodrug activation in bolus cyclophosphamide-treated cultured tumor cells. Impact of prodrug schedule on P450 gene-directed enzyme prodrug therapy.
    Schwartz PS; Chen CS; Waxman DJ
    Cancer Gene Ther; 2003 Aug; 10(8):571-82. PubMed ID: 12872138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between cell density and the secretion of von Willebrand factor and prostacyclin by human umbilical vein endothelial cells.
    Wissink MJ; Beernink R; Poot AA; Engbers GH; Beugeling T; van Aken WG; Feijen J
    Biomaterials; 2001 Aug; 22(16):2283-90. PubMed ID: 11456068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial activation and injury by cigarette smoke exposure.
    Guarino F; Cantarella G; Caruso M; Russo C; Mancuso S; Arcidiacono G; Cacciola RR; Bernardini R; Polosa R
    J Biol Regul Homeost Agents; 2011; 25(2):259-68. PubMed ID: 21880215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
    Spielmann H; Jacob-Müller U
    Teratology; 1981 Feb; 23(1):7-13. PubMed ID: 7245091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.